pCSL is expanding its external innovation capability, and we're looking for a Senior Director of Search Evaluation to help shape the future of our Immunology portfolio. /p pWe are seeking a bSenior Director of Search Evaluation /b to lead strategic sourcing and evaluation of later-stage external clinical assets in bImmunology /b. This leader will focus on opportunities from Phase 2 through marketed drugs, requiring deep clinical expertise, strong engagement with external Key Opinion Leaders (KOLs) and clinical investigators, and a keen understanding of evolving standards of care. The role is critical to shaping our portfolio through high-impact partnerships and transactions. /p pTo be hybrid-based onsite (3 days a week) at one of our RD hub sites: Zurich (CH), Maidenhead (UK), Waltham (US), King of Prussia (US). This position cannot be held remotely /p h3Main Responsibilities Accountabilities /h3 ul liServe as the senior SE leader within the Therapy Area Leadership Team, influencing therapeutic strategy and integrating late-stage external innovation priorities into portfolio planning. /li liLead proactive sourcing efforts for Phase 2 to marketed assets, identifying opportunities that align with TA strategy and unmet medical needs. /li liCo-lead internal meetings (with Early Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within Immunology. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations. /li liEngage extensively with external KOLs, clinical investigators, and networks to validate asset potential, understand trial designs clinical endpoints, and anticipate competitive dynamics. /li liMaintain deep awareness of changing standards of care and competitive landscapes to inform sourcing priorities and deal strategy. /li liDrive cross-functional due diligence for late-stage assets, coordinating clinical, regulatory, commercial, and market access assessments to support governance decisions. /li liPartner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution /li liRepresent the TA externally, leading sourcing activities at specialized conferences and building relationships with pharma, biotech, and clinical communities. /li /ul h3Qualifications Experience Requirements /h3 ul li15+ years in biopharma with significant experience in clinical development, external innovation, or business development. /li liAdvanced degree required (MD, PhD, or equivalent). /li liDeep clinical expertise in Immunology /li liProven track record of sourcing and closing late-stage deals and engaging with KOLs and clinical networks. /li liStrong understanding of regulatory pathways, market access, and competitive standards of care. /li /ul h3About CSL Behring /h3 pCSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives. /p pCSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries. /p pTo learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit and CSL Plasma at . /p h3Our Benefits /h3 pFor more information on CSL benefits visit How CSL Supports Your Well-being | CSL ( . /p h3You Belong at CSL /h3 pAt CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future. /p pTo learn more about inclusion and belonging visit /p h3Equal Opportunity Employer /h3 pCSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit . /p pR- /p pCSL makes all employment decisions without regard to race, color, religion, national origin, ancestry, age, sex, gender, pregnancy, disability, marital status, sexual orientation, gender identity, genetic information, military status, protected veteran status (specifically status as a disabled veteran, recently separated veteran, armed forces service medal veteran, or active duty wartime or campaign badge veteran) or other classification protected by applicable US federal, state or local law. CSL complies with all applicable employment laws, including but not limited to Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act, the Fair Labor Standards Act, and the Immigration Reform and Control Act. /p #J-18808-Ljbffr
Senior Director, Search & Evaluation Late TA Lead, Immunology Arbeitgeber: CSL Behring
CSL Behring ist ein hervorragender Arbeitgeber, der seinen Mitarbeitenden in Marburg nicht nur ein hochtechnisiertes Arbeitsumfeld bietet, sondern auch eine Vielzahl von Vorteilen wie überdurchschnittliche Verdienstmöglichkeiten, Weihnachts- und Urlaubsgeld sowie Unterstützung bei individuellen Herausforderungen. Die Unternehmenskultur fördert Teamarbeit und Eigenverantwortung, während die Möglichkeit zur beruflichen Weiterentwicklung und ein planbares Schichtsystem dazu beitragen, dass Mitarbeitende eine ausgewogene Work-Life-Balance genießen können.